Atrion Corporation (ATRI) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Atrion Corporation  (NASDAQ: ATRI)


Atrion's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Atrion's ROI in the second quarter of 2024?
Atrion Corporation achieved a return on average invested assets (ROI) of 5.14 % in its second quarter of 2024, which is below Atrion's average return on investment, which stands at 15.82%.

ROI decreased relative to the period ending Mar 31 2024, due to the decline in net income.

Within the Healthcare sector 137 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2024 from 928 to 1355.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM 0.03 % -0.52 % -2.51 % 26.97 % 25.89 %
Y / Y Net Income Change TTM -53.85 % -37.59 % -26.78 % 17.17 % 191.07 %
Investment (TTM) in Millions 239 242 251 245 245
Return On Investment (TTM) 5.14 % 7.62 % 7.93 % 8.74 % 11.15 %
ATRI's Overall Ranking # 1355 # 928 # 904 # 751 #
Seq. Investment Change TTM -0.6 % 0.34 % 0.46 % -0.16 % -1.14 %
Seq. Net Income Change TTM -32.91 % -3.57 % -8.91 % -21.68 % -9.29 %
Net Income (TTM) in Millions 13 19 19 21 27

ATRI Company Profile >> Back to ATRI Roi Comparisons >> See Annual ATRI Return On Investment



Return On Investment ATRI's Ranking
Within: No.
Industry # 40
Sector # 138
Overall # 1355

Return On Investment Statistics
High Average Low
19.66 %
15.82 %
5.14 %
(Dec 31 2017)   (Jun 30 2024)







Financial Statements
Atrion's II. Quarter Investments $ 239 Millions ATRI's Balance sheet
Atrion's II. Quarter Income $ 0 Millions Quarterly ATRI's Income Statement
ATRI's Income by Division See ATRI's Income by Division


ATRI Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 251 247 14 251 221
Y / Y Investment Growth 1.82 % 1684.55 % -94.49 % 13.47 % 13.82 %
Net Income in Millions 19 35 32 37 34
Y / Y Net Income Growth -44.55 % 9.01 % -12.64 % 7.32 % -6.39 %
Annual Return On Investment 7.73 % 14.2 % 232.39 % 14.66 % 15.5 %


Annual Roi Comment
In the fiscal year 2023 ROI decreased relative to the previous year to 7.73 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ATRI's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ATRI's Competitors
Subscribers only: Roi for Atrion's Suppliers
Subscribers only: Return On Investment for ATRI's Customers

Other Ratios
ATRI's Roa ATRI's Inventory Turnover Ratio ATRI's Growth Rates ATRI's Dividend Statistics
ATRI's Profitability Ratios ATRI's Asset Turnover Ratio ATRI's Dividend Growth
ATRI's Roe ATRI's Valuation Ratios ATRI's Financial Strength Ratios ATRI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI
Catalyst Pharmaceuticals Inc   14.12 %
Ufp Technologies Inc   13.99 %
Msa Safety Inc  13.63 %
Dexcom Inc   13.62 %
Sensus Healthcare Inc   13.32 %
Reflect Scientific Inc  13.25 %
Krystal Biotech Inc   13.24 %
X4 Pharmaceuticals Inc  13.16 %
Tactile Systems Technology Inc   13.16 %
Prestige Consumer Healthcare Inc   13.09 %
Innoviva Inc   13.05 %
Tenet Healthcare Corp  12.97 %
Neurocrine Biosciences Inc   12.91 %
Precision Biosciences Inc  12.81 %
Amphastar Pharmaceuticals Inc   12.79 %
Electromed Inc   12.57 %
Arcutis Biotherapeutics Inc   12.55 %
Utah Medical Products Inc  12.22 %
Third Harmonic Bio Inc   12.19 %
Kiora Pharmaceuticals Inc   12.00 %
Adma Biologics Inc   11.88 %
Lemaitre Vascular Inc   11.71 %
Progyny Inc   11.56 %
Waters Corporation  11.38 %
Baxter International Inc   10.99 %
Organon and Co   10.99 %
Align Technology inc   10.86 %
Stryker Corp  10.72 %
Relmada Therapeutics Inc  10.56 %
Bruker Corporation  10.38 %

Date modified: 2024-09-15T09:08:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.